Janney Montgomery Scott LLC purchased a new position in shares of Aspen Aerogels, Inc. (NYSE:ASPN - Free Report) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 106,613 shares of the construction company's stock, valued at approximately $681,000. Janney Montgomery Scott LLC owned approximately 0.13% of Aspen Aerogels as of its most recent filing with the SEC.
Other institutional investors also recently modified their holdings of the company. Exchange Traded Concepts LLC raised its position in shares of Aspen Aerogels by 460.4% during the first quarter. Exchange Traded Concepts LLC now owns 7,436 shares of the construction company's stock worth $48,000 after purchasing an additional 6,109 shares during the period. Sandia Investment Management LP purchased a new stake in Aspen Aerogels in the 4th quarter valued at $89,000. Penbrook Management LLC purchased a new stake in Aspen Aerogels in the 1st quarter valued at $116,000. Wealth Enhancement Advisory Services LLC purchased a new stake in Aspen Aerogels in the 4th quarter valued at $129,000. Finally, AlphaQuest LLC raised its position in Aspen Aerogels by 54.0% in the 4th quarter. AlphaQuest LLC now owns 11,395 shares of the construction company's stock valued at $135,000 after buying an additional 3,998 shares during the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.
Analyst Ratings Changes
A number of research firms recently commented on ASPN. Barclays reissued an "equal weight" rating and issued a $7.00 price target (down from $13.00) on shares of Aspen Aerogels in a research report on Thursday, May 29th. Oppenheimer lowered Aspen Aerogels from an "outperform" rating to a "market perform" rating in a research report on Thursday, May 8th. Finally, TD Cowen raised Aspen Aerogels to a "strong-buy" rating in a research report on Tuesday, March 11th. One investment analyst has rated the stock with a sell rating, three have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $18.44.
View Our Latest Analysis on ASPN
Aspen Aerogels Stock Performance
Shares of Aspen Aerogels stock traded up $0.12 during trading hours on Friday, hitting $6.46. 673,506 shares of the company's stock traded hands, compared to its average volume of 2,014,661. Aspen Aerogels, Inc. has a 12-month low of $4.16 and a 12-month high of $33.15. The stock has a market capitalization of $530.43 million, a price-to-earnings ratio of -1.85 and a beta of 2.65. The company has a fifty day simple moving average of $5.94 and a 200-day simple moving average of $7.97. The company has a debt-to-equity ratio of 0.40, a current ratio of 4.22 and a quick ratio of 3.53.
Aspen Aerogels (NYSE:ASPN - Get Free Report) last posted its quarterly earnings results on Thursday, May 8th. The construction company reported ($0.06) earnings per share for the quarter, topping the consensus estimate of ($0.07) by $0.01. The company had revenue of $78.72 million during the quarter, compared to the consensus estimate of $82.75 million. Aspen Aerogels had a positive return on equity of 6.69% and a negative net margin of 65.47%. The firm's quarterly revenue was down 16.7% compared to the same quarter last year. During the same quarter in the prior year, the company earned ($0.02) EPS. Equities research analysts anticipate that Aspen Aerogels, Inc. will post 0.17 EPS for the current fiscal year.
Insider Buying and Selling at Aspen Aerogels
In other news, CEO Donald R. Young purchased 20,000 shares of the business's stock in a transaction dated Monday, May 12th. The stock was bought at an average price of $5.35 per share, for a total transaction of $107,000.00. Following the purchase, the chief executive officer owned 550,856 shares of the company's stock, valued at $2,947,079.60. The trade was a 3.77% increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 4.30% of the company's stock.
Aspen Aerogels Profile
(
Free Report)
Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.
Featured Articles

Before you consider Aspen Aerogels, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Aspen Aerogels wasn't on the list.
While Aspen Aerogels currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.